Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-16

Clinical Trial Update: A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566 [Phase 1]

View source ↗

Summary

Sanofi completed a Phase 1 trial evaluating the photosafety of SAR441566 in rheumatoid arthritis, using placebo and an active comparator.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SAR441566 (SAR441566)

Snippet

Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED